2021
DOI: 10.1080/03639045.2021.1908334
|View full text |Cite
|
Sign up to set email alerts
|

Formulation of chitosan coated nanoliposomes for the oral delivery of colistin sulfate: in vitro characterization, 99mTc-radiolabeling and in vivo biodistribution studies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
7
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(8 citation statements)
references
References 64 publications
1
7
0
Order By: Relevance
“…As observed in Fig. S1 ( supplementary data ), the particle size was increased after stabilization with biosurfactant, which is in coherence with the previous reports (Aboumanei et al, 2021 ; Gorjian et al, 2021 ). After the encapsulation of bioactive agent (nisin) in RS-NCS, particle size further increased.…”
Section: Resultssupporting
confidence: 92%
“…As observed in Fig. S1 ( supplementary data ), the particle size was increased after stabilization with biosurfactant, which is in coherence with the previous reports (Aboumanei et al, 2021 ; Gorjian et al, 2021 ). After the encapsulation of bioactive agent (nisin) in RS-NCS, particle size further increased.…”
Section: Resultssupporting
confidence: 92%
“…Aboumanei et al executed in vivo biodistribution studies of thigh muscle Escherichia coli infection-bearing mice with chitosan-coated liposomes encapsulating colistin and showed that upon oral administration, the bioavailability of colistin in the blood was improved more than 5-fold for chitosan-coated liposomes compared to a colistin solution. In addition, the localization of colistin at the infection site was improved by 125-fold for their formulation 1 h postadministration [48]. Thus, the coating of AMP-loaded liposomes with chitosan increases the effectivity and improves the bioavailability of AMP upon oral administration.…”
Section: Liposomesmentioning
confidence: 99%
“…The red fluorescence as depicted in Figure 11 demonstrates a higher uptake of Rhodamine B CS-LIPO in cells, indicating augmented penetration of the liposomes mainly in the cytoplasm region and more intensely in the nucleus owing to positively charged chitosan coating that could uphold endocytic cellular uptake via cell membrane interaction and the small size of liposomes lying in the nanometric range resulting in immense incorporation inside the cells. 36 The higher uptake displayed by rhodamine B-loaded CS-LIPO is anticipated to result in a more efficient antitumor action. However, plain rhodamine B dye in the rhodamine B solution cell was incapable of penetrating the MCF-7 cells.…”
Section: In Vitro Drug Release Studymentioning
confidence: 99%